# GLUE (Monte Rosa Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Monte Rosa Therapeutics, Inc. reported $70.33M in revenue and a net loss of $130.9M for the trailing twelve months ended September 30, 2026 (up 325.8% year over year), with a -214.5% operating margin.

- Canonical: https://convexityos.com/fundamentals/GLUE
- Markdown: https://convexityos.com/fundamentals/GLUE.md
- SEC CIK: 0001826457
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:31 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001826457&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $70.33M | +325.8% YoY |
| Operating Income | TTM | -$150.8M | -214.5% margin |
| Net Income | TTM | -$130.9M | -186.2% net margin |
| Diluted EPS | TTM | -$1.21 | Split-adjusted |
| Free Cash Flow | TTM | -$174.4M | -248.0% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $45.18M | Total debt: $36.27M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $123.7M | $75.62M | $0 | -- | -- | -- |
| Research & Development | $141.5M | $121.6M | $111.3M | $85.06M | $57.16M | $24.00M |
| Total Operating Expenses | $177.9M | $156.7M | $143.3M | $112.4M | $72.88M | $28.01M |
| **Operating Income** | -$54.21M | -$81.11M | -$143.3M | -$112.4M | -$72.88M | -$28.01M |
| **EBITDA** | -$43.35M | -$70.89M | -$135.0M | -$106.1M | -$70.75M | -$27.47M |
| Income Before Tax | -$39.72M | -$70.13M | -$135.0M | -$108.5M | -- | -- |
| Income Tax Expense | -$1.10M | $2.57M | $338K | $0 | -- | -- |
| **Net Income** | -$38.60M | -$72.70M | -$135.4M | -$108.5M | -$73.96M | -$35.88M |
| Basic EPS | -- | -- | -- | -- | -$2.96 | -$23.65 |
| **Diluted EPS** | -- | -- | -- | -- | -$2.96 | -$23.65 |
| Basic Shares Outstanding | 83.1M | 73.9M | 51.4M | 47.2M | 25.0M | 1.5M |
| Diluted Shares Outstanding | 83.1M | 73.9M | 51.4M | 47.2M | 25.0M | 1.5M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $54.37M | $8.97M | $4.21M | $2.78M | $12.77M | $23.19M | $84.93M | $60.65M |
| Research & Development | $45.36M | $47.96M | $44.07M | $41.98M | $36.68M | $30.65M | $32.19M | $38.87M |
| Total Operating Expenses | $56.30M | $58.10M | $54.24M | $52.50M | $45.74M | $38.75M | $40.89M | $47.64M |
| **Operating Income** | -$1.94M | -$49.13M | -$50.03M | -$49.72M | -$32.98M | -$15.55M | $44.04M | $13.00M |
| **EBITDA** | $920K | -$46.51M | -$47.36M | -$46.95M | -$30.24M | -$12.81M | $46.66M | $15.58M |
| Income Before Tax | $3.78M | -$43.19M | -$44.45M | -$46.08M | -$30.26M | -$11.10M | $47.71M | $15.60M |
| Income Tax Expense | $716K | $208K | $52K | $59K | -$3.18M | $1.20M | $822K | $2.16M |
| **Net Income** | $3.06M | -$43.40M | -$44.50M | -$46.11M | -$27.08M | -$12.29M | $46.88M | $13.44M |
| Basic Shares Outstanding | 101.8M | 101.5M | 99.9M | -- | 82.4M | 82.2M | 82.1M | -- |
| Diluted Shares Outstanding | 108.6M | 101.5M | 99.9M | -- | 82.4M | 82.2M | 83.0M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $129.9M | $224.3M | $128.1M | $54.91M | $346.1M | $41.70M |
| **Cash & Short-Term Investments** | $377.1M | $224.3M | $128.1M | $54.91M | $346.1M | $41.70M |
| **Total Current Assets** | $393.2M | $377.4M | $236.2M | $275.9M | $348.7M | $43.59M |
| Property, Plant & Equipment, Net | $25.99M | $29.48M | $33.80M | $27.07M | $12.32M | $4.62M |
| Other Non-Current Assets | $148K | $115K | $352K | $278K | $0 | -- |
| **Total Non-Current Assets** | $55.47M | $61.29M | $67.54M | $66.50M | $17.66M | $5.79M |
| **Total Assets** | $448.7M | $438.7M | $303.8M | $342.4M | $366.3M | $49.38M |
| Accounts Payable | $3.55M | $17.21M | $11.15M | $7.86M | $6.56M | $7.07M |
| Deferred Revenue (Current) | $29.57M | $117.2M | $17.68M | $0 | -- | -- |
| Other Current Liabilities | -- | $3.35M | $1.67M | $5.02M | $840K | $1.40M |
| **Total Current Liabilities** | $64.21M | $156.9M | $46.59M | $25.57M | $16.64M | $29.27M |
| **Total Non-Current Liabilities** | $151.4M | $58.85M | $77.91M | $45.41M | $2.18M | $1.07M |
| **Total Liabilities** | $215.6M | $215.8M | $124.5M | $70.98M | $18.81M | $30.34M |
| **Total Debt (incl. Leases)** | $39.19M | $42.72M | $46.04M | $47.00M | -- | -- |
| Common Stock | $7.0K | $6.0K | $5.0K | $5.0K | $5.0K | $1.0K |
| Retained Earnings | -$477.2M | -$438.6M | -$365.9M | -$230.5M | -$122.0M | -$48.08M |
| Accumulated Other Comp. Income | -$3.83M | -$3.36M | -$2.72M | -$1.75M | -$2.02M | -$1.06M |
| **Total Stockholders' Equity** | $233.1M | $222.9M | $179.2M | $271.4M | $347.5M | -$48.73M |
| Total Equity | $233.1M | $222.9M | $179.2M | $271.4M | $347.5M | -$48.73M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $45.18M | $90.10M | $159.9M | $129.9M | $208.3M | $69.43M | $78.53M | $224.3M |
| **Cash & Short-Term Investments** | $577.7M | $621.1M | $666.2M | $377.1M | $391.3M | $290.6M | $78.53M | $224.3M |
| **Total Current Assets** | $640.1M | $631.4M | $677.5M | $393.2M | $401.8M | $299.5M | $332.3M | $377.4M |
| Property, Plant & Equipment, Net | $28.63M | $29.93M | $28.41M | $25.99M | $27.60M | $29.05M | $29.34M | $29.48M |
| Other Non-Current Assets | $767K | $828K | $832K | $148K | $411K | $445K | $440K | $115K |
| **Total Non-Current Assets** | $57.66M | $59.76M | $58.88M | $55.47M | $58.02M | $60.12M | $60.92M | $61.29M |
| **Total Assets** | $697.7M | $691.2M | $736.4M | $448.7M | $459.8M | $359.6M | $393.2M | $438.7M |
| Accounts Payable | $3.35M | $7.15M | $7.90M | $3.55M | $14.51M | $5.58M | $6.49M | $17.21M |
| Deferred Revenue (Current) | $21.10M | $22.10M | $33.06M | $29.57M | $24.79M | $18.41M | $32.58M | $117.2M |
| Other Current Liabilities | -- | -- | -- | -- | $1.65M | $1.51M | $4.42M | $3.35M |
| **Total Current Liabilities** | $62.05M | $59.66M | $71.04M | $64.21M | $61.44M | $41.85M | $59.22M | $156.9M |
| **Total Non-Current Liabilities** | $139.5M | $144.2M | $143.5M | $151.4M | $152.6M | $49.65M | $58.82M | $58.85M |
| **Total Liabilities** | $201.5M | $203.9M | $214.5M | $215.6M | $214.0M | $91.51M | $118.0M | $215.8M |
| **Total Debt (incl. Leases)** | $36.27M | $37.99M | $39.06M | $39.19M | $40.17M | $41.13M | $41.86M | $42.72M |
| Common Stock | $9.0K | $9.0K | $8.0K | $7.0K | $6.0K | $6.0K | $6.0K | $6.0K |
| Retained Earnings | -$562.1M | -$565.1M | -$521.7M | -$477.2M | -$431.1M | -$404.0M | -$391.7M | -$438.6M |
| Accumulated Other Comp. Income | -$6.19M | -$5.17M | -$4.75M | -$3.83M | -$3.25M | -$3.37M | -$3.33M | -$3.36M |
| **Total Stockholders' Equity** | $496.2M | $487.3M | $521.9M | $233.1M | $245.8M | $268.1M | $275.2M | $222.9M |
| Total Equity | $496.2M | $487.3M | $521.9M | $233.1M | $245.8M | $268.1M | $275.2M | $222.9M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$38.63M | -$72.70M | -$135.4M | -$108.5M | -$73.96M | -$35.88M |
| Depreciation & Amortization | $10.86M | $10.22M | $8.32M | $6.25M | $2.13M | $537K |
| Stock-Based Compensation | $18.86M | $18.13M | $16.67M | $11.66M | $5.20M | $354K |
| Change in Payables | -$13.71M | $6.25M | $5.76M | -$744K | -$706K | $3.44M |
| **Operating Cash Flow** | -$22.80M | $42.00M | -$43.80M | -$92.47M | -$59.36M | -$23.05M |
| Capital Expenditure | -$4.70M | -$3.99M | -$19.04M | -$12.91M | -$9.73M | -$3.39M |
| **Free Cash Flow** | -$27.50M | $38.01M | -$62.84M | -$105.4M | -$69.09M | -$26.44M |
| Purchases of Investments | -$376.7M | -$230.4M | -$103.2M | -$384.4M | $0 | -- |
| **Investing Cash Flow** | -$101.8M | -$44.45M | $88.80M | -$219.2M | -$9.65M | -$3.39M |
| Common Stock Issued | $345.0M | -- | $0 | $20.05M | $0 | -- |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | -- |
| **Financing Cash Flow** | $30.35M | $98.89M | $27.49M | $20.47M | $377.6M | $60.06M |
| **Net Change in Cash** | -$94.28M | $96.44M | $72.49M | -$291.2M | $308.5M | $33.62M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $3.06M | -$43.40M | -$44.50M | -$46.13M | -$27.08M | -$12.29M | $46.88M | $13.44M |
| Depreciation & Amortization | $2.86M | $2.62M | $2.67M | $2.76M | $2.73M | $2.74M | $2.62M | $2.57M |
| Stock-Based Compensation | $6.32M | $5.97M | $5.95M | $4.31M | $4.36M | $4.89M | $5.30M | $4.47M |
| Change in Payables | -$3.40M | -$1.49M | $4.38M | -$10.61M | $8.88M | -$1.10M | -$10.87M | $13.31M |
| **Operating Cash Flow** | -$40.98M | -$44.11M | -$37.37M | -$43.01M | $100.4M | -$34.72M | -$45.49M | $128.9M |
| Capital Expenditure | -$1.56M | -$4.72M | -$1.87M | -$767K | -$651K | -$1.70M | -$1.59M | -$183K |
| **Free Cash Flow** | -$42.54M | -$48.84M | -$39.24M | -$43.78M | $99.78M | -$36.41M | -$47.08M | $128.7M |
| Purchases of Investments | -$91.71M | -$76.07M | -$332.0M | -$153.7M | -$65.97M | -$19.03M | -$138.0M | -$67.96M |
| **Investing Cash Flow** | -$4.54M | -$28.86M | -$261.0M | -$65.07M | $38.14M | $25.32M | -$100.2M | -$30.90M |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Financing Cash Flow** | $568K | $3.21M | $328.3M | $29.62M | $348K | $365K | $14K | $608K |
| **Net Change in Cash** | -$44.95M | -$69.76M | $29.97M | -$78.46M | $138.9M | -$9.03M | -$145.7M | $98.63M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -43.8% | -107.3% | -- | -- | -- | -- |
| **Net Profit Margin** | -31.2% | -96.1% | -- | -- | -- | -- |
| Return on Equity (ROE) | -16.6% | -32.6% | -75.5% | -40.0% | -21.3% | -- |
| Return on Assets (ROA) | -8.6% | -16.6% | -44.6% | -31.7% | -20.2% | -72.7% |
| Current Ratio | 6.12x | 2.40x | 5.07x | 10.79x | 20.96x | 1.49x |
| Quick Ratio | 5.87x | 1.43x | 2.75x | 2.15x | 20.80x | 1.42x |
| Debt to Equity | 0.17x | 0.19x | 0.26x | 0.17x | -- | -- |
| **Revenue Growth (YoY)** | +63.5% | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -154.3% | -- | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -172.3% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -214.5% | -633.0% | -345.2% | -43.8% | 4.7% | 8.4% | -1.3% | -107.3% |
| **Net Profit Margin** | -186.2% | -560.8% | -302.6% | -31.2% | 11.5% | 13.6% | 3.9% | -96.1% |
| Return on Equity (ROE) | -26.4% | -33.1% | -24.9% | -16.6% | 8.5% | 9.0% | 2.2% | -32.6% |
| Return on Assets (ROA) | -18.8% | -23.3% | -17.7% | -8.6% | 4.6% | 6.7% | 1.6% | -16.6% |
| Current Ratio | 10.32x | 10.58x | 9.54x | 6.12x | 6.54x | 7.16x | 5.61x | 2.40x |
| Quick Ratio | 9.31x | 10.41x | 9.38x | 5.87x | 6.37x | 6.94x | 1.33x | 1.43x |
| Debt to Equity | 0.07x | 0.08x | 0.07x | 0.17x | 0.16x | 0.15x | 0.15x | 0.19x |
| **Revenue Growth (YoY)** | +325.8% | -61.3% | -95.0% | -95.4% | +38.5% | +394.0% | +7882.0% | -- |
| Operating Income Growth (YoY) | -- | -- | -213.6% | -482.3% | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -194.9% | -443.1% | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -140.8% | -- | -- | -133.4% | -- | -- | -- | +335.0% |
| Free Cash Flow Growth (YoY) | -142.6% | -- | -- | -134.0% | -- | -- | -- | +360.7% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
